Ocean Deity, the majority stakeholder, charged that the sums were disbursed for loans taken by the infra company from the bank, without its authorisation
No pharma company is taking up patent issues with the WTO as they are looking to sort out the issue through treaties, says Kewal Handa, Former MD of Pfizer.